当社は、数百に及ぶ特許化合物に対する測定法の開発及びバリデーションを行うことで、多くの製薬会社とパートナーシップを築いてまいりました。現在当社では、一連のバリデートされた測定法を構築しておりますので、御社の要望に沿った測定法のリクエストをお知らせください。
現在有効なバリデートされた非特許化合物の測定法は以下の通りです:
| List of Validated Assays | |||||
|---|---|---|---|---|---|
| ALL | A-F | G-L | M-R | S-Z | |
| COMPOUND | MATRIX | CALIBRATION RANGE | Anti-Coag | LTMS | TEMP | Acamprosate | Human Plasma | 0.500 to 200 ng/mL | - |
|---|---|---|---|---|---|
| AFMU | Human Urine | 100 - 20,000 ng/mL | None | 244 | -20 |
| Albuterol | Human Plasma | 1.00 - 1,000 pg/mL | |||
| Aliskiren | Human Plasma | 1.00 - 500 ng/mL | K2EDTA | 204 | -20 |
| Amlodipine | Human Plasma | 0.500 - 100 ng/mL | EDTA | 47 | -20 |
| Amprenavir | Human Plasma | 10.0 - 10,000 ng/mL | K3EDTA | 72 | -20 |
| Aprepitant | Human Plasma | 10.0 - 5,000 ng/mL | K3EDTA | 214 | -20 |
| Armodafinil | Human Plasma | 100 - 10,000 ng/mL | K3EDTA | 102 | -20 |
| Atazanavir | Human Plasma | 5.0 - 2,500 ng/mL | K2EDTA | 49 | -20,-70 |
| Atazanavir / Ritonavir | Human Plasma | 1.00 - 1,000 ng/mL | EDTA | -20 | |
| Atazanavir / Ritonavir | Human Plasma | 10.0 - 5,000 ng/mL | K3EDTA | 446 | -20 |
| Atorvastatin/ o-Hydroxy / p-Hydroxy | Human Plasma | 0.300 - 50.0 ng/mL | K2EDTA | 220 | -20 |
| Atorvastatin/ o-Hydroxy / p-Hydroxy | Human Plasma | 0.300 - 50.0 ng/mL | K2EDTA | 224 | -70 |
| Atorvastatin / Lactone / o-Hydroxy / p-Hydroxy | Human Plasma | 0.100 - 100 ng/mL | K2EDTA | 224 | -70 |
| Bortezomib | Human Plasma | 0.100 - 25.00 ng/mL | K2EDTA | 611 | -70 |
| Budesonide | Human Plasma | 10.0 to 5,000 pg/mL | K2EDTA | 123 | -20 |
| Buprenorphine/Norbuprenorphine | Human Plasma | 25.0 - 10,000 / 20 - 8,000 pg/mL | |||
| Buproprion/ Hydroxybuproprion/ Ethrohydroxybupropion / Threohydroxybuproprion |
Human Plasma | 1.00 - 1,000 ng/mL | K2EDTA | 223 | -70 |
| Caffeine | Human Plasma | 10.0 - 10,000 ng/mL | K2EDTA | 223 | -20 |
| Capcitebine / 5'-Deoxy-5-fluorocytidine / 5'-Deoxy-5-fluorouidine | Human Plasma | 10.0 - 5,000 ng/mL | Na2 EDTA | 240 | -20 |
| Carboplatin | Human Plasma Ultrafiltrate |
50.0 - 40,000 ng/mL | K2EDTA | 262 | -70 |
| Carboplatin | Human Plasma | 100 - 50,000 ng/mL | |||
| Carvedilol | Human Plasma | 0.200 - 200 ng/mL | EDTA | 560 | -70 |
| Cinacalcet | Human Plasma | 0.100 - 50.00 ng/mL | K3EDTA | 252 | -20 |
| Ciprofloxacin / Levofloxacin / Moxifloxacin | Human Plasma | 10.0 - 1,000 ng/mL | |||
| Cyclobenzaprine | Human Plasma | 0.100 - 50.0 ng/mL | K2EDTA | 121 | -20 |
| Cytarabine/Ara-U | Human Plasma | 200 - 50,000 ng/mL | K2EDTA | 258 | -20 |
| Darifenacin | Human Plasma | 50.0 - 10,000 pg/mL | K2EDTA | 119 | -20 |
| Daunorubicin | Human Plasma | 0.100 - 10.0 ng/mL | EDTA | 200 | -70 |
| Daunorubicin/Daunorubicinol | Rat Plasma | 10.0 - 1,000 ng/mL | EDTA | 211 | -70 |
| Daunorubicin/Daunorubicinol | Dog Plasma | 10.0 - 1,000 ng/mL | EDTA | 211 | -70 |
| Dexlansoprazole | Human Plasma | 2.00 - 2,000 ng/mL | K2EDTA | 104 | -20 |
| Dexlansoprazole | Human Plasma | 2.00 - 2,000 ng/mL | K2EDTA | 84 | -70 |
| Dextromethorphan/Dextrorphan | Human Plasma | 0.500 - 250 ng/mL | K2EDTA | 273 | -20 |
| Dextromethorphan/Dextrorphan | Human Urine | 1.00 - 500 ng/mL | K2EDTA | 89 | -20 |
| Diclofenac | Human Plasma | 0.100 - 100 ng/mL | NaHep | 64 | -20 |
| Diclofenac | Human Plasma | 10.00 - 2,000 ng/mL | K2EDTA | 84 | -20 |
| Digoxin | Human Plasma | 0.100 to 50.0 ng/mL | K2EDTA | 177 | -20 |
| Docetaxel | Human Plasma | 5.00 - 5,000 ng/mL | K2EDTA | 80 | -20 |
| Donepezil | Human Plasma | 0.100 - 100 ng/mL | K3EDTA | 206 | -20 |
| Doxorubicin/Doxorubicinol | Human Plasma | 1.00 - 1,000 ng/mL | EDTA | 211 | -70 |
| Duloxetine | Human Plasma | 0.200 - 100 ng/mL | K3EDTA | 184 | -20 |
| Efavirenz | Human Plasma | 10.0 - 10,000 ng/mL | K2EDTA | 260 | -20 |
| Emtracitabine | Human Plasma | 5.00 - 5,000 ng/mL | K2EDTA | 330 | -20 |
| Entecavir | Human Plasma | 50.0 - 20,000 pg/mL | K2EDTA | 42,49 | -20,-70 |
| Erlotinib and Metabolite | Human Plasma | 10.0 - 4,000 ng/mL | K2EDTA | 315 | -70 |
| even | Human Plasma | 1.00 - 500 pg/mL | |||
| Estrone | Human Plasma | 5.00 - 2,500 pg/mL | |||
| Eszopiclone | Human Plasma | 1.00 - 100 ng/mL | K3EDTA | 235 | -20 |
| Ethinyl Estradiol | Human Plasma | 1.00 - 500 pg/mL | |||
| Famotidine | Human Plasma | 1.00 - 500 ng/mL | K3EDTA | 298 | -20 |
| Fentanyl | Human Plasma | 0.0500 - 50.0 ng/mL | K2EDTA | Pending | -20,-70 |
| Fluconazole | Human Plasma | 100 - 10,000 ng/mL | K3EDTA | 133 | -20 |
| 5-Fluorouracil | Human Plasma | 1.00 - 500 ng/mL | EDTA | 1095 | -20 |
| Fluticasone propionate / Salmeterol | Human Plasma | 1.00 - 200 pg/mL | K2EDTA/K3EDTA | 91 | -20 |
| Formoterol | Human Plasma | 10.0-10000 ng/mL | K2EDTA | ||
| Furosemide | Human Plasma | 10.0-10000 ng/mL | K2EDTA |